Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

50 results
Display

The Frequency of and Risk Factors for the Use of Bisphosphonates in the Adjuvant Setting of Primary Breast Cancer in Germany

Fick EM, Katalinic , Waldmann A

PURPOSE: The aim of this cross-sectional health care study (use of bisphosphonates in primary tumors of the mammae, EBisMa) is to determine how often bisphosphonate medication is used in patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute

Choi Y, Keam B, Kim TM, Lee SH, Kim DW, Heo DS

PURPOSE: The purpose of this study was to investigate and compare cancer treatment near the end-of-life (EOL) over a 10-year period. MATERIALS AND METHODS: Patients with advanced solid cancer at Seoul...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report

Woo HS, Lee KH, Yoon PH, Kim SJ, Park I, Kim YS, Ahn HK, Hong J, Shin DB, Sym SJ

Oxaliplatin is a third-generation platinum derivative used for metastatic or advanced colorectal cancer treatment. Although myelosuppression is the most common cause of oxaliplatin-induced thrombocytopenia, rare cases of oxaliplatin-induced immune-mediated thrombocytopenia...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Epidermal Growth Factor Receptor Mutation Status in the Treatment of Non-small Cell Lung Cancer: Lessons Learned

Lee DH, Srimuninnimit V, Cheng R, Wang X, Orlando M

Advances in oncology research have led to identification of tumor-specific biomarkers, some of which are important predictive indicators and ideal targets for novel therapeutics. One such biomarker in non-small cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Incidence and Treatment Pattern of Extremity Soft Tissue Sarcoma in Korea, 2009-2011: A Nationwide Study Based on the Health Insurance Review and Assessment Service Database

Kang S, Kim HS, Choi ES, Han I

PURPOSE: We conducted a nationwide study to assess the incidence and treatment patterns of extremity soft tissue sarcoma (STS) in South Korea. MATERIALS AND METHODS: The nationwide incidence and treatment patterns...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Economic Burden of Breast Cancer in Korea from 2007-2010

Kim YA, Oh IH, Yoon SJ, Kim HJ, Seo HY, Kim EJ, Lee YH, Jung JH

PURPOSE: This study estimates the socioeconomic cost and burden for breast cancer patients in Korea between 2007 and 2010. MATERIALS AND METHODS: This study used a prevalence-based approach to estimate the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor

Cho JH, Lim JY, Choi AR, Choi SM, Kim JW, Choi SH, Cho JY

PURPOSE: This study was conducted to validate the survival benefit of metastasectomy plus chemotherapy over chemotherapy alone for treatment of Krukenberg tumors from gastric cancer and to identify prognostic factors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oncologist Perspectives on Rare Cancer Care: A Nationwide Survey

Shin DW, Cho J, Yang HK, Kim SY, Lee SH, Suh B, Shin HY, Lee HJ, Kim DG, Park JH

PURPOSE: In response to the challenges and difficulties imposed by rare cancers, multi-stakeholder initiatives dedicated to improving rare cancer care was launched, and several recommendations were made by professional societies....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors

Oh DY, Lee SH, Han SW, Kim MJ, Kim TM, Kim TY, Heo DS, Yuasa M, Yanagihara Y, Bang YJ

PURPOSE: OPB-31121 is an oral STAT3 inhibitor with a good preclinical antitumor activity. This phase I dose-escalation study of OPB-31121 was conducted to determine maximum-tolerated dose (MTD), safety, pharmacokinetics, and...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia

Hong JH, Lee SE, Choi SY, Kim SH, Jang EJ, Bang JH, Park JE, Jeon HR, Oh YJ, Yi JE, Jung HO, Youn HJ, Kim DW

We describe two cases of pulmonary arterial hypertension (PAH) that occurred under dasatinib treatment and were resolved after dasatinib discontinuation. Two patients with chronic phase chronic myeloid leukemia (CML) were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
APE1/Ref-1 as a Serological Biomarker for the Detection of Bladder Cancer

Shin JH, Choi S, Lee YR, Park MS, Na YG, Irani K, Lee SD, Park JB, Kim JM, Lim JS, Jeon BH

PURPOSE: Apurinic/apyrimidinic endonuclease 1/redox factor-1 (APE1/Ref-1) is a multifunctional protein that shows elevated expression in a number of cancers. We attempted to determine whether serum APE1/Ref-1 is elevated in patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Oncologists' Experience with Patients with Second Primary Cancer and the Attitudes toward Second Primary Cancer Screening: A Nationwide Survey

Shin DW, Cho J, Yang HK, Kim SY, Park B, Cho B, Kim HJ, Lee YJ, Jo DY, Park JH

PURPOSE: Screening for second primary cancer (SPC) is one of the key components to survivorship care. We aim to evaluate the oncologists' experience with SPCs and assess the current practice,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Optimal Interval for Repeated Gastric Cancer Screening in Normal-Risk Healthy Korean Adults: A Retrospective Cohort Study

Bae JM, Shin SY, Kim EH

PURPOSE: This retrospective cohort study was conducted to estimate the optimal interval for gastric cancer screening in Korean adults with initial negative screening results. MATERIALS AND METHODS: This study consisted of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Population-based Incidence and Survival for Primary Central Nervous System Lymphoma in Korea, 1999-2009

Shin SH, Jung KW, Ha J, Lee SH, Won YJ, Yoo H

PURPOSE: Primary central nervous system lymphoma (PCNSL) is an uncommon brain tumor accounting for 2%-5% of all primary brain tumors. Few population-based analyses of survival for patients with PCNSL have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Detecting Metastatic Bladder Cancer Using 18F-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography

Ozturk H

PURPOSE: The purpose of this study was to retrospectively investigate the contribution of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography (18F-FDG-PET/CT) to detection of metastatic bladder cancer. MATERIALS AND METHODS: The present study included...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy

Wu SG, Li Q, Zhou J, Sun JY, Li FY, Lin Q, Lin HX, Gaun XX, He ZY

PURPOSE: This study was conducted to investigate the prognostic value of lymph node ratio (LNR) in stage II/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy. MATERIALS AND METHODS: Clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Efficacy and Safety of Platinum/Vinorelbine as More Than Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer

Song IC, Lee HJ, Yang YJ, Choi YS, Ryu HW, Lee MW, Moon JY, Jo DY, Kim S, Yun HJ

PURPOSE: There is no regimen that is strongly recommended for more than second-line treatment. We investigated the efficacy and safety of platinum/vinorelbine as more than second-line treatment. MATERIALS AND METHODS: We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure

Lim YJ, Wu HG, Kwon TK, Hah JH, Sung MW, Kim KH, Park CI

PURPOSE: This study evaluates the long-term results of definitive radiotherapy (RT) for early glottic cancer. Clinical and treatment factors related to local control and patterns of failure are analyzed. MATERIALS AND...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?

Kim ST, Chang WJ, Jin L, Sung JS, Choi YJ, Kim YH

PURPOSE: KRAS mutations have been used widely as prognostic or predictive marker in patients with advanced colorectal cancer (CRC). However, it may be difficult to obtain a tumor tissue for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term Outcome of Chondrosarcoma: A Single Institutional Experience

Bindiganavile S, Han I, Yun JY, Kim HS

PURPOSE: The prognostic factors of chondrosarcoma remain uncertain as only a few large studies with long-term follow-up have been reported. The aim of this study was to analyze oncological outcomes...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr